Global Pentasa (Ulcerative Colitis) Market Professional Survey Report 2016

July 2016 | 105 pages | ID: GCB7A0794F3EN
QYResearch

Abstracts

This report mainly covers the following

Product types including

• Pentasa tablets
• Pentasa granules

The segment applications including

• Ulcerative colitis
• Crohn's disease

Segment regions including (the separated region report can also be offered)

• EU
• USA
• India
• Japan
• China

The players list (Partly, Players you are interested in can also be added)

• Ferring GmbH
• Laboratórios Ferring Ltda
• Shire US Inc.
• Takeda’s Entyvio
• Prescription Hope, Inc
• GiCare
• Treato
• Prasco

With no less than 10 top producers.

Data including (both global and regions): Market Size (both volume - Kg and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/g, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Contents

1 INDUSTRY OVERVIEW OF PENTASA (ULCERATIVE COLITIS)

1.1 Definition and Specifications of Pentasa (Ulcerative Colitis)
  1.1.1 Definition of Pentasa (Ulcerative Colitis)
  1.1.2 Specifications of Pentasa (Ulcerative Colitis)
1.2 Classification of Pentasa (Ulcerative Colitis)
  1.2.1 Pentasa tablets
  1.2.2 Pentasa granules
1.3 Applications of Pentasa (Ulcerative Colitis)
  1.3.1 Ulcerative colitis
  1.3.2 Crohn's disease
1.4 Industry Chain Structure of Pentasa (Ulcerative Colitis)
1.5 Industry Overview and Major Regions Status of Pentasa (Ulcerative Colitis)
  1.5.1 Industry Overview of Pentasa (Ulcerative Colitis)
  1.5.2 Global Major Regions Status of Pentasa (Ulcerative Colitis)
1.6 Industry Policy Analysis of Pentasa (Ulcerative Colitis)
1.7 Industry News Analysis of Pentasa (Ulcerative Colitis)

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PENTASA (ULCERATIVE COLITIS)

2.1 Raw Material Suppliers and Price Analysis of Pentasa (Ulcerative Colitis)
2.2 Equipment Suppliers and Price Analysis of Pentasa (Ulcerative Colitis)
2.3 Labor Cost Analysis of Pentasa (Ulcerative Colitis)
2.4 Other Costs Analysis of Pentasa (Ulcerative Colitis)
2.5 Manufacturing Cost Structure Analysis of Pentasa (Ulcerative Colitis)
2.6 Manufacturing Process Analysis of Pentasa (Ulcerative Colitis)

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PENTASA (ULCERATIVE COLITIS)

3.1 Capacity and Commercial Production Date of Global Pentasa (Ulcerative Colitis) Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Pentasa (Ulcerative Colitis) Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Pentasa (Ulcerative Colitis) Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Pentasa (Ulcerative Colitis) Major Manufacturers in 2015

4 GLOBAL PENTASA (ULCERATIVE COLITIS) OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Pentasa (Ulcerative Colitis) Capacity and Growth Rate Analysis
  4.2.2 2015 Pentasa (Ulcerative Colitis) Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Pentasa (Ulcerative Colitis) Sales and Growth Rate Analysis
  4.3.2 2015 Pentasa (Ulcerative Colitis) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Pentasa (Ulcerative Colitis) Sales Price
  4.4.2 2015 Pentasa (Ulcerative Colitis) Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Pentasa (Ulcerative Colitis) Gross Margin
  4.5.2 2015 Pentasa (Ulcerative Colitis) Gross Margin Analysis (Company Segment)

5 PENTASA (ULCERATIVE COLITIS) REGIONAL MARKET ANALYSIS

5.1 EU Pentasa (Ulcerative Colitis) Market Analysis
  5.1.1 EU Pentasa (Ulcerative Colitis) Market Overview
  5.1.2 EU 2011-2016E Pentasa (Ulcerative Colitis) Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 EU 2011-2016E Pentasa (Ulcerative Colitis) Sales Price Analysis
  5.1.4 EU 2015 Pentasa (Ulcerative Colitis) Market Share Analysis
5.2 USA Pentasa (Ulcerative Colitis) Market Analysis
  5.2.1 USA Pentasa (Ulcerative Colitis) Market Overview
  5.2.2 USA 2011-2016E Pentasa (Ulcerative Colitis) Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 USA 2011-2016E Pentasa (Ulcerative Colitis) Sales Price Analysis
  5.2.4 USA 2015 Pentasa (Ulcerative Colitis) Market Share Analysis
5.3 India Pentasa (Ulcerative Colitis) Market Analysis
  5.3.1 India Pentasa (Ulcerative Colitis) Market Overview
  5.3.2 India 2011-2016E Pentasa (Ulcerative Colitis) Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 India 2011-2016E Pentasa (Ulcerative Colitis) Sales Price Analysis
  5.3.4 India 2015 Pentasa (Ulcerative Colitis) Market Share Analysis
5.4 Japan Pentasa (Ulcerative Colitis) Market Analysis
  5.4.1 Japan Pentasa (Ulcerative Colitis) Market Overview
  5.4.2 Japan 2011-2016E Pentasa (Ulcerative Colitis) Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2011-2016E Pentasa (Ulcerative Colitis) Sales Price Analysis
  5.4.4 Japan 2015 Pentasa (Ulcerative Colitis) Market Share Analysis
5.5 China Pentasa (Ulcerative Colitis) Market Analysis
  5.5.1 China Pentasa (Ulcerative Colitis) Market Overview
  5.5.2 China 2011-2016E Pentasa (Ulcerative Colitis) Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 China 2011-2016E Pentasa (Ulcerative Colitis) Sales Price Analysis
  5.5.4 China 2015 Pentasa (Ulcerative Colitis) Market Share Analysis

6 GLOBAL 2011-2016E PENTASA (ULCERATIVE COLITIS) SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Pentasa (Ulcerative Colitis) Sales by Type
6.2 Different Types Pentasa (Ulcerative Colitis) Product Interview Price Analysis
6.3 Different Types Pentasa (Ulcerative Colitis) Product Driving Factors Analysis
  6.3.1 Pentasa tablets Pentasa (Ulcerative Colitis) Growth Driving Factor Analysis
  6.3.2 Pentasa granules Pentasa (Ulcerative Colitis) Growth Driving Factor Analysis

7 GLOBAL 2011-2016E PENTASA (ULCERATIVE COLITIS) SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
  7.3.1 Ulcerative colitis Pentasa (Ulcerative Colitis) Growth Driving Factor Analysis
  7.3.2 Crohn's disease Pentasa (Ulcerative Colitis) Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PENTASA (ULCERATIVE COLITIS)

8.1 Ferring GmbH
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Ferring GmbH 2015 Pentasa (Ulcerative Colitis) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Ferring GmbH 2015 Pentasa (Ulcerative Colitis) Business Region Distribution Analysis
8.2 Laboratórios Ferring Ltda
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Laboratórios Ferring Ltda 2015 Pentasa (Ulcerative Colitis) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Laboratórios Ferring Ltda 2015 Pentasa (Ulcerative Colitis) Business Region Distribution Analysis
8.3 Shire US Inc.
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Shire US Inc. 2015 Pentasa (Ulcerative Colitis) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Shire US Inc. 2015 Pentasa (Ulcerative Colitis) Business Region Distribution Analysis
8.4 Takeda’s Entyvio
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Takeda’s Entyvio 2015 Pentasa (Ulcerative Colitis) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Takeda’s Entyvio 2015 Pentasa (Ulcerative Colitis) Business Region Distribution Analysis
8.5 Prescription Hope, Inc
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Prescription Hope, Inc 2015 Pentasa (Ulcerative Colitis) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Prescription Hope, Inc 2015 Pentasa (Ulcerative Colitis) Business Region Distribution Analysis
8.6 GiCare
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 GiCare 2015 Pentasa (Ulcerative Colitis) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 GiCare 2015 Pentasa (Ulcerative Colitis) Business Region Distribution Analysis
8.7 Treato
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Treato 2015 Pentasa (Ulcerative Colitis) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Treato 2015 Pentasa (Ulcerative Colitis) Business Region Distribution Analysis
8.8 Prasco
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 Prasco 2015 Pentasa (Ulcerative Colitis) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Prasco 2015 Pentasa (Ulcerative Colitis) Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 EU 2016-2021 Pentasa (Ulcerative Colitis) Consumption Forecast
  9.2.2 USA 2016-2021 Pentasa (Ulcerative Colitis) Consumption Forecast
  9.2.3 India 2016-2021 Pentasa (Ulcerative Colitis) Consumption Forecast
  9.2.4 Japan 2016-2021 Pentasa (Ulcerative Colitis) Consumption Forecast
  9.2.5 China 2016-2021 Pentasa (Ulcerative Colitis) Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 PENTASA (ULCERATIVE COLITIS) MARKETING MODEL ANALYSIS

10.1 Pentasa (Ulcerative Colitis) Regional Marketing Model Analysis
10.2 Pentasa (Ulcerative Colitis) International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Pentasa (Ulcerative Colitis) by Regions
10.4 Pentasa (Ulcerative Colitis) Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PENTASA (ULCERATIVE COLITIS)

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF PENTASA (ULCERATIVE COLITIS)

12.1 New Project SWOT Analysis of Pentasa (Ulcerative Colitis)
12.2 New Project Investment Feasibility Analysis of Pentasa (Ulcerative Colitis)

13 CONCLUSION OF THE GLOBAL PENTASA (ULCERATIVE COLITIS) MARKET PROFESSIONAL SURVEY REPORT 2016